SHAWN VANGRONIGEN: Open Payments
NPI 1386928703 · HANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 49 payments from 10 companies in 2025. Trend: 2023 $1,130 · 2024 $729 · 2025 $841
Food & beverage: $831Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $283 |
| ABBVIE INC. | 11 | $256 |
| GENZYME CORPORATION | 6 | $121 |
| Incyte Corporation | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Arcutis Biotherapeutics, Inc. | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| LEO Pharma Inc. | 1 | $21 |
| UCB, Inc. | 1 | $16 |
| Organon LLC | 1 | $9 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, OPZELURA, COSENTYX, Zoryve, LIBTAYO, ADBRY.
Industry payments across CA — which companies pay providers there.
